CLINICAL_TRIALS
trial_result
· 2019-09-12
Clinical Trial Update: Trial of Daily Pulse Interleukin-2 With Famotidine in Acute Myelogenous Leukemia [Phase 2]
Summary
Phase 2 trial of daily pulse interleukin-2 with famotidine in acute myeloid leukemia was terminated; results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Leo W. Jenkins Cancer Center | Conditions: Acute Myelogenous Leukemia | Phase 2 | Status: TERMINATED | Results posted: 2019-09-12